| Literature DB >> 32272980 |
Shohei Egami1, Jun Yamagami2, Masayuki Amagai3.
Abstract
Autoimmune bullous skin diseases, such as pemphigus and pemphigoid, may enable clarification of the mechanisms of immune regulation in the skin. Pemphigus and pemphigoid are mediated by essentially IgG autoantibodies against structural proteins of the desmosomes at cell-cell junctions and hemidesmosomes at epidermal-dermal junctions, respectively, and are characterized by blisters and erosions in the skin and/or mucous membranes. Intensive investigation over the last 3 decades has identified their target antigens and developed serological diagnostic tools as well as mouse models to help us understand their pathophysiology. Based on these advances, several new therapeutic approaches have become available, and more effective and less toxic targeted approaches are under development.Entities:
Keywords: Autoimmune bullous diseases; BP180; ELISA; desmoglein; rituximab; type XVII collagen BP230
Year: 2020 PMID: 32272980 DOI: 10.1016/j.jaci.2020.02.013
Source DB: PubMed Journal: J Allergy Clin Immunol ISSN: 0091-6749 Impact factor: 10.793